title: Weekly high-dose liposomal amphotericin B for secondary prophylaxis of invasive fungal disease in immunocompromised children: experience from a pediatric case series.
authors.affiliation: Istituto Giannina Gaslini, Genoa, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Ginocchio
authors.forename: Maura
authors.initials: M
authors.lastname: Faraci
authors.forename: Francesca
authors.initials: F
authors.lastname: Fioredda
authors.forename: Cristina
authors.initials: C
authors.lastname: Moroni
authors.forename: Ilaria
authors.initials: I
authors.lastname: Caviglia
authors.forename: Paola
authors.initials: P
authors.lastname: Barabino
authors.forename: Riccardo
authors.initials: R
authors.lastname: Haupt
authors.forename: Elio
authors.initials: E
authors.lastname: Castagnola
mesh_terms: D000293:Adolescent; D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D057239:Early Termination of Clinical Trials; D005260:Female; D006776:Hospitals, Pediatric; D006801:Humans; D016867:Immunocompromised Host; D008081:Liposomes; D008172:Lung Diseases, Fungal / Q000276:immunology / Q000517:prevention & control; D008297:Male; D009181:Mycoses / Q000276:immunology / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D000935:Antifungal Agents; D008081:Liposomes; D000666:Amphotericin B